Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 385 entries
View as:

Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT05437380 Org: User:
Start: 09/20/22 End: 06/28/26 Due: 06/28/27

Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT06366945 Org: User:
Start: 04/20/24 End: 05/30/29 Due: 05/30/30

Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04551287 Org: User:
Start: 07/01/19 End: 12/14/20 Due: 12/14/21

Ductal Lavage in Non-lactating Female Women With Mastitis

Phase: N/A Priority: Normal
NCT ID: NCT02794688 Org: User:
Start: 08/31/16 End: 06/05/19 Due: 06/05/20

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04962958 Org: User:
Start: 07/01/23 End: 08/31/24 Due: 08/31/25

Diagnostic Efficacy of Metagenomic Next-generation Sequencing in Patients With Spinal Infections: A Retrospective Study

Phase: N/A Priority: Normal
NCT ID: NCT06172153 Org: User:
Start: 06/01/23 End: 05/01/24 Due: 05/01/25

Effects of Music Combined With CBT on Chronic Subjective Tinnitus

Phase: N/A Priority: Normal
NCT ID: NCT06505473 Org: User:
Start: 12/01/16 End: 06/01/24 Due: 06/01/25

Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male

Phase: N/A Priority: Normal
NCT ID: NCT05018429 Org: User:
Start: 10/01/21 End: 09/30/23 Due: 09/30/24

Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT05316376 Org: User:
Start: 05/01/22 End: 04/30/25 Due: 04/30/26

Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01869569 Org: User:
Start: 02/28/13 End: 01/31/17 Due: 01/31/18

Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02982148 Org: User:
Start: 05/31/15 End: 01/31/17 Due: 01/31/18

Multimodal Analysis of Structural Voice Disorders Based on Speech and Stroboscopic Laryngoscope Video

Phase: N/A Priority: Normal
NCT ID: NCT05348031 Org: User:
Start: 05/06/22 End: 02/20/27 Due: 02/20/28

A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT05444673 Org: User:
Start: 06/01/22 End: 12/01/24 Due: 12/01/25

The Therapeutic Effect of Thalidomide in RI

Phase: N/A Priority: Normal
NCT ID: NCT03208413 Org: User:
Start: 07/19/17 End: 07/30/20 Due: 07/30/21

Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06144944 Org: User:
Start: 01/17/24 End: 12/31/31 Due: 12/31/32

Exploratory Study on the Application of Virtual Augmented Reality Combined With Finder in Preoperative Anterolateral Thigh Flap Perforator Positioning

Phase: N/A Priority: Normal
NCT ID: NCT06277687 Org: User:
Start: 02/15/24 End: 07/15/24 Due: 07/15/25

Multimodal Imaging Diagnosis and Decision Aid System for Hepatic Echinococcosis Based on Image Omics and Vision Macromodel

Phase: N/A Priority: Normal
NCT ID: NCT06540742 Org: User:
Start: 09/30/23 End: 09/12/24 Due: 09/12/25

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04718415 Org: User:
Start: 01/23/21 End: 01/23/27 Due: 01/23/28

A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC

Phase: N/A Priority: Normal
NCT ID: NCT04501523 Org: User:
Start: 08/03/20 End: 08/31/32 Due: 08/31/33

Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)

Phase: N/A Priority: Normal
NCT ID: NCT05724329 Org: User:
Start: 02/05/23 End: 08/05/28 Due: 08/05/29

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06992336 Org: User:
Start: 04/10/25 End: 01/01/36 Due: 01/01/37

Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT06599801 Org: User:
Start: 09/30/24 End: 09/30/25 Due: 09/30/26

A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics

Phase: N/A Priority: Normal
NCT ID: NCT05251883 Org: User:
Start: 01/01/22 End: 12/31/26 Due: 12/31/27

Distribution of Bacteria in OME After Radiotherapy For NPC.

Phase: N/A Priority: Normal
NCT ID: NCT06523933 Org: User:
Start: 05/12/24 End: 05/12/25 Due: 05/12/26

The Mechanism of Vaginal Flora and Its Metabolites in the Pathogenesis of Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05185713 Org: User:
Start: 04/01/22 End: 01/01/23 Due: 01/01/24